Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kane Biotech Inc (KNE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3411
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company serves industrial, human and animal healthcare industries. It conducts research and development programs through its on-site CL2 biofilm research laboratory in Canada. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc (KNE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Equity Offering 13
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Debt Offering 23
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc – Key Competitors 24
Kane Biotech Inc – Key Employees 25
Kane Biotech Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 21, 2018: Kane Biotech announces second quarter 2018 financial results 27
May 17, 2018: Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements 29
Mar 21, 2018: Kane Biotech – 2017 Year End and Fourth Quarter Financial Results and Business Update 30
Nov 14, 2017: Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options 32
Aug 16, 2017: Kane Biotech – Q2 2017 Financial Results 33
May 17, 2017: Kane Biotech – Q1 2017 Financial Reports 34
Corporate Communications 35
May 22, 2018: Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors 35
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 36
Legal and Regulatory 37
Feb 26, 2018: Kane Biotech Sues Nestle 37
Other Significant Developments 38
Aug 09, 2018: Kane Biotech retains strategic expert in securing non-dilutive funding opportunities in the United States 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Kane Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 11
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 12
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 13
Kane Biotech Raises USD3 Million in Private Placement of Units 14
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 15
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 16
Kane Biotech Raises USD0.17 Million in Private Placement of Shares upon Exercise of Warrants 17
Kane Biotech Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 18
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 19
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 20
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 22
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 23
Kane Biotech Inc, Key Competitors 24
Kane Biotech Inc, Key Employees 25

List of Figures
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aavin Equity Advisors, LLC:企業の戦略・SWOT・財務情報
    Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report Summary Aavin Equity Advisors, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Alexion Pharmaceuticals Inc (ALXN)-製薬・医療分野:企業M&A・提携分析
    Summary Alexion Pharmaceuticals Inc (Alexion) focuses on developing and delivering life-changing drug therapies for patients with serious and ultra-rare disorders. The company develops biologic therapeutic products for the treatment of severe disease states, including genetic diseases, hematologic d …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • ReShape Medical Inc-医療機器分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • Neonc Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeOnc Technologies Inc (NTI) is an early-stage cancer biotechnology company that focuses on the development of intranasal inhalation and other non-invasive therapies for the treatment of malignant brain cancer, lung cancer and other brain cancers. The company’s product portfolio includes NEO …
  • SandRidge Energy, Inc.:企業の戦略・SWOT・財務分析
    SandRidge Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary SandRidge Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Lear Corporation:企業の戦略・SWOT・財務情報
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Gulf Cement Company PSC:企業の戦略・SWOT・財務情報
    Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report Summary Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NTN Corporation:企業の戦略・SWOT・財務情報
    NTN Corporation - Strategy, SWOT and Corporate Finance Report Summary NTN Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Assore Limited:企業の戦略・SWOT・財務情報
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Aqeri International AB:企業の戦略的SWOT分析
    Aqeri International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Celltrion Inc (068270):企業の財務・戦略的SWOT分析
    Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • State Corporation Bank for Development and Foreign Economic Affairs:電力:M&Aディール及び事業提携情報
    Summary State Corporation Bank for Development and Foreign Economic Affairs (Vnesheconombank) is a bank that offers investment banking and funding services. The company funds and supports investment projects and industrial exports through credits, guarantees and sureties, economic entities authorize …
  • PVR Ltd:企業のM&A・事業提携・投資動向
    PVR Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PVR Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Probiodrug AG (PBD):製薬・医療:M&Aディール及び事業提携情報
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Actelion Ltd:企業の戦略・SWOT・財務情報
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BE Semiconductor Industries NV (BESI):企業の財務・戦略的SWOT分析
    BE Semiconductor Industries NV (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆